Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator


 
  Mycophenolate Mofetil Tablets 250 mg
  Indications :
 

For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.

   
  Dosage :
  Renal Transplantation :

Adults : A dose of 1 g administered orally twice a day (daily dose of 2 g) is recommended for use in renal transplant patients.

Pediatrics : Patients with a body surface area of 1.25 m² to 1.5 m² (3 months to 18 years) may be given a dose of 750 mg twice daily (1.5 g daily dose). Patients with a body surface area > 1.5 m² may be dosed with at a dose of 1 g twice daily (2 g daily dose).

Cardiac Transplantation :

Adults : A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.

Hepatic Transplantation

Adults : A dose of 1.5g BID oral (daily dose of 3g) is recommended for use in adult cardiac transplant patients.

Dosage Adjustment :

Renal Impairment : Not required.

Hepatic Impairment : May be required in renal patients with some hepatic diseases.
   
  Packing : 6 Strips of 10 Tablets
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.